TITLE

NOVADEL SELECTS INYX TO PRODUCE NITROGLYCERIN LINGUAL SPRAY

PUB. DATE
January 2005
SOURCE
Worldwide Biotech;Jan2005, Vol. 17 Issue 1, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the selection of Inyx Inc. by Novadel Pharma Inc. to produce NovaDel's nitroglycerin lingual spray for the treatment of acute angina, under an exclusive five-year contract. Terms of the contract; Statement from Jack Kachkar, M. D., chairman and CEO of Inyx, on the selection; Targeted date for Inyx to commence production of the NovaDel product.
ACCESSION #
15501431

 

Related Articles

  • NovaDel Signs Exclusive License and Distribution Agreement with Rechon Life Science AB to Manufacture and Commercialize Zolpimist(r) outside the US and Canada.  // Biomedical Market Newsletter;9/12/2011, Vol. 21, p389 

    The article reports on the agreement of exclusive license and distribution agreement of NovaDel Pharma Inc. with Rechon Life Science AB to manufacture and commercialize Zolpimist(r) oral spray outside Canada and the U.S. Under the terms of the agreement, Rechon will pay a royalty on each unit...

  • NEW DRUGS.  // Drug Topics;1/8/2007, Vol. 151 Issue 1, p59 

    The article evaluates the Verdeso Foam from NovaDel Pharma Inc.

  • NovaDel Pharma Inc. to Present at 2011 BIO International Convention.  // Biomedical Market Newsletter;6/30/2011, p97 

    The article offers information on the 2011 Biotechnology Industry Organization (BIO) International Convention that will be organized by NovaDel Pharma Inc. at the Walter E. Washington Convention Center in Washington D.C. from June 27-30.

  • NOVADEL ISSUES 2004 FISCAL YEAR UPDATE.  // Biotech Financial Reports;Oct2004, p4 

    This article presents information on achievements of NovaDel Pharma Inc. for the financial year 2004. It is informed that in a fiscal year update to shareholders, NovaDel Pharma, Inc., Flemington, New Jersey, has reported that all its product development programs are moving forward and that it...

  • Pharma firm makes bold bid for partner. Kaltwasser, Jared // njbiz;1/23/2012, Vol. 25 Issue 4, p3 

    The article reports that NovaDel Pharma Inc. is looking for a partnership to prevent it from going bankrupt.

  • Dependence on nitro paste? R.M.D. // Cortlandt Forum;6/25/96, Vol. 9 Issue 6, p116 

    Presents an answer to the query regarding the possible development of tolerance or dependence with the use of nitroglycerin paste for conditions that would respond to vascular dilatation, such as peripheral vascular insufficiency and impotence. Mechanism of action; Efficacy; Incidences of...

  • NEWSLINE.  // MPR - Pharmacist's Edition;Spring2011, Vol. 5 Issue 1, pA.12 

    The article presents several drugs and vitamins for various diseases including Intuniv from Shire Pharmaceuticals Group PLC, the prenatal vitamin Nexa Select, and Zolpimist from NovaDel Pharma and ECR Pharmaceuticals.

  • Financings Roundup.  // BioWorld Today;2/16/2011, Vol. 22 Issue 32, p4 

    This article reports on the securities purchase agreement signed by NovaDel Pharma Inc. to raise 1.6 million U.S. dollars in gross proceeds via the sale of 1,667 shares of Series A convertible preferred stock to institutional investors.

  • Financings Roundup.  // BioWorld Today;4/1/2010, Vol. 21 Issue 62, p6 

    This article reports on the purchase agreement signed by NovaDel Pharma Inc. to raise 1.5 million U.S. dollars via the sale of nine million shares of its common stock to institutional investors.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics